Outlook Therapeutics, Inc.

OTLK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 13, 2026
8-K Sep 30, 2026 FORM 8-K
8-K Sep 18, 2026 FORM 8-K
4 Sep 2, 2026
3 Sep 2, 2026
8-K Aug 27, 2026 FORM 8-K
SCHEDULE 13G Aug 19, 2026
10-Q Aug 18, 2026 10-Q
NT 10-Q Aug 17, 2026 NT 10-Q
4 Aug 14, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Aug 14, 2026
4 Aug 14, 2026 FORM 4
4 Aug 14, 2026 PRIMARY DOCUMENT
8-K Aug 14, 2026 FORM 8-K
424B5 Aug 14, 2026 424B5
8-K Aug 14, 2026 FORM 8-K
424B5 Aug 12, 2026 424B5
8-K Aug 12, 2026 FORM 8-K
4 Jul 29, 2026 PRIMARY DOCUMENT
8-K Jul 24, 2026 FORM 8-K
8-K Jul 24, 2026 FORM 8-K
4 Jul 23, 2026 PRIMARY DOCUMENT
4 Jul 23, 2026 PRIMARY DOCUMENT
EFFECT Jul 21, 2026
424B3 Jul 21, 2026 424B3
← Newer Page 1 of 34 · 833 filings Older →